A carregar...
Infliximab treatment in pathology-confirmed neurosarcoidosis
OBJECTIVE: To assess the efficacy and risks of treatment with infliximab (anti–tumor necrosis factor alpha) in pathology-confirmed neurosarcoidosis. METHODS: In a retrospective study in 2 tertiary referral centers in the Netherlands, we analyzed clinical characteristics, complications, and outcome o...
Na minha lista:
| Publicado no: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7413716/ https://ncbi.nlm.nih.gov/pubmed/32718952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000847 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|